全球腸內餵養配方市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

全球腸內餵養配方奶粉市場需求預計將從 2022 年的 96.2 億美元增至 2030 年的近 187.9 億美元，2023-2030 年研究期間年複合成長率為 7.72%。

腸內餵養配方食品也稱為管飼配方食品，用於治療癌症、進食障礙、慢性病、危及生命的傷害以及中風或發作等疾病。術語腸內餵養描述了通過胃腸道攝入食物的過程。胃、食道、腸和口腔構成胃腸道。通過管子攝取的營養直接進入胃和小腸。這種形式的餵養方法是作為補充。這種餵養方法使患者能夠獲得保持胃腸道活躍的營養。

市場動態：

腸內餵養配方奶粉市場的強勁成長是由於癌症、癡呆、中風、多發性硬化症、慢性阻塞性肺病（COPD）、肝臟疾病和其他慢性疾病的患病率不斷上升而推動的。早產的增加是促進市場成長的另一個主要因素。癌症發病率的上升、從醫院到門診護理機構的轉變以及癌症患者擴大接受腸內餵養配方作為腸外營養的有效替代品，可能會推動腫瘤學應用中對腸內餵養配方的需求。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球腸內餵養配方奶粉市場的各個細分市場進行了包容性評估。腸內餵養配方奶粉行業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲腸內餵養配方奶粉市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。腸內餵養配方奶粉市場的主要參與者包括雅培、達能、費森尤斯卡比、雀巢、Victus, Inc.、Primus Pharmaceuticals, Inc.、明治控股。有限公司和 Rickett Benckiser Group Plc。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：腸內餵養配方 - 行業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 行業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 按流量類型分類的市場吸引力分析
  • 分階段市場吸引力分析
  • 按指標進行的市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 按銷售管道分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球腸內餵養配方奶粉市場分析：按產品分類

• 按產品概述
• 歷史和預測數據
• 按產品分析
• 標準配方
• 特定疾病配方

第 7 章：全球腸內餵養配方市場分析：按流程類型

• 按流程類型概述
• 歷史和預測數據
• 按流量類型分析
• 間歇式餵料流程
• 連續進料流量

第 8 章：全球腸內餵養配方奶粉市場分析：按階段

• 階段概覽
• 歷史和預測數據
• 階段分析
• 成人
• 兒科

第 9 章：全球腸內餵養配方奶粉市場分析：按適應症分類

• 按適應症概述
• 歷史和預測數據
• 按指標分析
• 老年失智症
• 營養缺乏
• 癌症護理
• 糖尿病
• 慢性腎臟病
• 孤兒病
• 吞嚥困難
• 疼痛管理
• 吸收不良/胃腸道疾病/腹瀉
• 其他

第 10 章：全球腸內餵養配方奶粉市場分析：按最終用戶分類

• 最終用戶概述
• 歷史和預測數據
• 最終用戶分析
• 醫院（心臟病科、神經科、重症監護 (ICU)、腫瘤科、其他）
• 家庭護理

第 11 章：全球腸內餵養配方奶粉市場分析：按銷售管道

• 銷售管道概覽
• 歷史和預測數據
• 按銷售管道分析
• 網上銷售
• 機構銷售
• 零售銷售

第 12 章：全球腸內餵養配方奶粉市場銷售分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家/地區銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家/地區銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家/地區銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 13 章：腸內餵養配方奶粉公司的競爭格局

• 腸內餵養配方奶粉市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 14 章：公司簡介

• 頂級公司股票分析
• 市場集中度
• Abbott
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Danone SA
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Fresenius Kabi
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Nestle
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Victus Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Primus Pharmaceuticals Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Meiji Holdings. Co. Ltd
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Rickett Benckiser Group Plc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

The global demand for Enteral Feeding Formulas Market is presumed to reach the market size of nearly USD 18.79 BN by 2030 from USD 9.62 BN in 2022 with a CAGR of 7.72% under the study period 2023 - 2030.

Enteral feeding formulas are also known as tube feeding formula considered for medical ailments such as cancer, eating inability, chronic illness, life-threatening injuries, and stroke or attacks. The term enteral feeding describes a procedure in which food is intake through the gastrointestinal tract. The stomach, esophagus, intestines, and mouth constitute the gastrointestinal tract. The nutrition taken via a tube goes directly to the stomach & small intestine. This form of feeding method is used as a supplement. This feeding method enables patients to receive the nutrition that keeps their gastrointestinal tract active.

MARKET DYNAMICS:

The robust growth of the enteral feeding formula market is driven by the increasing prevalence of cancer, dementia, stroke, multiple sclerosis, chronic obstructive pulmonary disease (COPD), liver ailments and other chronic diseases. The rise in preterm births is another major factor augmenting the market growth. The demand for enteral feeding formulas in oncological applications is likely to be fueled by the rising incidence of cancer, the transition from hospitals to outpatient care settings, and the growing acceptance of enteral feeding formulas as an efficient substitute for parenteral nutrition among cancer patients.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of enteral feeding formulas. The growth and trends of enteral feeding formulas industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the enteral feeding formulas market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Standard Formula
• Disease-Specific Formula

By Flow Type

• Intermittent Feeding Flow
• Continuous Feeding Flow

By Stage

• Adult
• Pediatric

By Indication

• Alzheimer'S
• Nutrition Deficiency
• Cancer Care
• Diabetes
• Chronic Kidney Diseases
• Orphan Diseases
• Dysphagia
• Pain Management
• Malabsorption/GI Disorder/Diarrhea
• Others

By End-User

• Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others)
• Home Care

By Sales Channel

• Online Sales
• Institutional Sales
• Retail Sales

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Enteral Feeding Formulas market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the enteral feeding formulas market include Abbott, Danone SA, Fresenius Kabi, Nestle, Victus, Inc., Primus Pharmaceuticals, Inc., Meiji Holdings. Co., Ltd and Rickett Benckiser Group Plc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ENTERAL FEEDING FORMULAS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Flow Type
  • 3.7.3 Market Attractiveness Analysis By Stage
  • 3.7.4 Market Attractiveness Analysis By Indication
  • 3.7.5 Market Attractiveness Analysis By End-user
  • 3.7.6 Market Attractiveness Analysis By Sales Channel
  • 3.7.7 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Standard Formula Historic and Forecast Sales by Regions
• 6.5 Disease-specific Formula Historic and Forecast Sales by Regions

7 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY FLOW TYPE

• 7.1 Overview by Flow Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Flow Type
• 7.4 Intermittent Feeding Flow Historic and Forecast Sales by Regions
• 7.5 Continuous Feeding Flow Historic and Forecast Sales by Regions

8 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY STAGE

• 8.1 Overview by Stage
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Stage
• 8.4 Adult Historic and Forecast Sales by Regions
• 8.5 Pediatric Historic and Forecast Sales by Regions

9 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY INDICATION

• 9.1 Overview by Indication
• 9.2 Historical and Forecast Data
• 9.3 Analysis by Indication
• 9.4 Alzheimer's Historic and Forecast Sales by Regions
• 9.5 Nutrition Deficiency Historic and Forecast Sales by Regions
• 9.6 Cancer Care Historic and Forecast Sales by Regions
• 9.7 Diabetes Historic and Forecast Sales by Regions
• 9.8 Chronic Kidney Diseases Historic and Forecast Sales by Regions
• 9.9 Orphan Diseases Historic and Forecast Sales by Regions
• 9.10. Dysphagia Historic and Forecast Sales by Regions
• 9.11 Pain Management Historic and Forecast Sales by Regions
• 9.12 Malabsorption/GI Disorder/Diarrhea Historic and Forecast Sales by Regions
• 9.13 Others Historic and Forecast Sales by Regions

10 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY END-USER

• 10.1 Overview by End-user
• 10.2 Historical and Forecast Data
• 10.3 Analysis by End-user
• 10.4 Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Historic and Forecast Sales by Regions
• 10.5 Home Care Historic and Forecast Sales by Regions

11 . GLOBAL ENTERAL FEEDING FORMULAS MARKET ANALYSIS BY SALES CHANNEL

• 11.1 Overview by Sales Channel
• 11.2 Historical and Forecast Data
• 11.3 Analysis by Sales Channel
• 11.4 Online Sales Historic and Forecast Sales by Regions
• 11.5 Institutional Sales Historic and Forecast Sales by Regions
• 11.6 Retail Sales Historic and Forecast Sales by Regions

12 . GLOBAL ENTERAL FEEDING FORMULAS MARKET SALES ANALYSIS BY GEOGRAPHY

• 12.1. Regional Outlook
• 12.2. Introduction
• 12.3. North America Sales Analysis
  • 12.3.1. Overview, Historic and Forecast Sales Analysis
  • 12.3.2. North America By Segment Sales Analysis
  • 12.3.3. North America By Country Sales Analysis
  • 12.3.4. United State Sales Analysis
  • 12.3.5. Canada Sales Analysis
  • 12.3.6. Mexico Sales Analysis
• 12.4. Europe Sales Analysis
  • 12.4.1. Overview, Historic and Forecast Sales Analysis
  • 12.4.2. Europe by Segment Sales Analysis
  • 12.4.3. Europe by Country Sales Analysis
  • 12.4.4. United Kingdom Sales Analysis
  • 12.4.5. France Sales Analysis
  • 12.4.6. Germany Sales Analysis
  • 12.4.7. Italy Sales Analysis
  • 12.4.8. Russia Sales Analysis
  • 12.4.9. Rest Of Europe Sales Analysis
• 12.5. Asia Pacific Sales Analysis
  • 12.5.1. Overview, Historic and Forecast Sales Analysis
  • 12.5.2. Asia Pacific by Segment Sales Analysis
  • 12.5.3. Asia Pacific by Country Sales Analysis
  • 12.5.4. China Sales Analysis
  • 12.5.5. India Sales Analysis
  • 12.5.6. Japan Sales Analysis
  • 12.5.7. South Korea Sales Analysis
  • 12.5.8. Australia Sales Analysis
  • 12.5.9. Rest Of Asia Pacific Sales Analysis
• 12.6. Latin America Sales Analysis
  • 12.6.1. Overview, Historic and Forecast Sales Analysis
  • 12.6.2. Latin America by Segment Sales Analysis
  • 12.6.3. Latin America by Country Sales Analysis
  • 12.6.4. Brazil Sales Analysis
  • 12.6.5. Argentina Sales Analysis
  • 12.6.6. Peru Sales Analysis
  • 12.6.7. Chile Sales Analysis
  • 12.6.8. Rest of Latin America Sales Analysis
• 12.7. Middle East & Africa Sales Analysis
  • 12.7.1. Overview, Historic and Forecast Sales Analysis
  • 12.7.2. Middle East & Africa by Segment Sales Analysis
  • 12.7.3. Middle East & Africa by Country Sales Analysis
  • 12.7.4. Saudi Arabia Sales Analysis
  • 12.7.5. UAE Sales Analysis
  • 12.7.6. Israel Sales Analysis
  • 12.7.7. South Africa Sales Analysis
  • 12.7.8. Rest Of Middle East And Africa Sales Analysis

13 . COMPETITIVE LANDSCAPE OF THE ENTERAL FEEDING FORMULAS COMPANIES

• 13.1. Enteral Feeding Formulas Market Competition
• 13.2. Partnership/Collaboration/Agreement
• 13.3. Merger And Acquisitions
• 13.4. New Product Launch
• 13.5. Other Developments

14 . COMPANY PROFILES OF ENTERAL FEEDING FORMULAS INDUSTRY

• 14.1. Top Company Share Analysis
• 14.2. Market Concentration Rate
• 14.3. Abbott
  • 14.3.1. Company Overview
  • 14.3.2. Company Revenue
  • 14.3.3. Products
  • 14.3.4. Recent Developments
• 14.4. Danone SA
  • 14.4.1. Company Overview
  • 14.4.2. Company Revenue
  • 14.4.3. Products
  • 14.4.4. Recent Developments
• 14.5. Fresenius Kabi
  • 14.5.1. Company Overview
  • 14.5.2. Company Revenue
  • 14.5.3. Products
  • 14.5.4. Recent Developments
• 14.6. Nestle
  • 14.6.1. Company Overview
  • 14.6.2. Company Revenue
  • 14.6.3. Products
  • 14.6.4. Recent Developments
• 14.7. Victus Inc.
  • 14.7.1. Company Overview
  • 14.7.2. Company Revenue
  • 14.7.3. Products
  • 14.7.4. Recent Developments
• 14.8. Primus Pharmaceuticals Inc.
  • 14.8.1. Company Overview
  • 14.8.2. Company Revenue
  • 14.8.3. Products
  • 14.8.4. Recent Developments
• 14.9. Meiji Holdings. Co. Ltd
  • 14.9.1. Company Overview
  • 14.9.2. Company Revenue
  • 14.9.3. Products
  • 14.9.4. Recent Developments
• 14.10. Rickett Benckiser Group Plc.
  • 14.10.1. Company Overview
  • 14.10.2. Company Revenue
  • 14.10.3. Products
  • 14.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Standard Formula Market Sales by Geography (USD MN)
• Disease-specific Formula Market Sales by Geography (USD MN)
• Analysis Market by Flow Type (USD MN)
• Intermittent Feeding Flow Market Sales by Geography (USD MN)
• Continuous Feeding Flow Market Sales by Geography (USD MN)
• Analysis by Stage (USD MN)
• Adult Market Sales by Geography (USD MN)
• Pediatric Market Sales by Geography (USD MN)
• Analysis by Indication (USD MN)
• Alzheimer's Market Sales by Geography (USD MN)
• Nutrition Deficiency Market Sales by Geography (USD MN)
• Cancer Care Market Sales by Geography (USD MN)
• Diabetes Market Sales by Geography (USD MN)
• Chronic Kidney Diseases Market Sales by Geography (USD MN)
• Orphan Diseases Market Sales by Geography (USD MN)
• Dysphagia Market Sales by Geography (USD MN)
• Pain Management Market Sales by Geography (USD MN)
• Malabsorption/GI Disorder/Diarrhea Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Market Sales by Geography (USD MN)
• Home Care Market Sales by Geography (USD MN)
• Analysis by Sales Channel (USD MN)
• Online Sales Market Sales by Geography (USD MN)
• Institutional Sales Market Sales by Geography (USD MN)
• Retail Sales Market Sales by Geography (USD MN)
• Global Enteral Feeding Formulas Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Enteral Feeding Formulas Report
• Market Research Process
• Market Research Methodology
• Global Enteral Feeding Formulas Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Flow Type
• Market Attractiveness Analysis by Stage
• Market Attractiveness Analysis by Indication
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Sales Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Standard Formula Market Sales by Geography (USD MN)
• Disease-specific Formula Market Sales by Geography (USD MN)
• Global Market Analysis by Flow Type (USD MN)
• Intermittent Feeding Flow Market Sales by Geography (USD MN)
• Continuous Feeding Flow Market Sales by Geography (USD MN)
• Global Market Analysis by Stage (USD MN)
• Adult Market Sales by Geography (USD MN)
• Pediatric Market Sales by Geography (USD MN)
• Global Market Analysis by Indication (USD MN)
• Alzheimer's Market Sales by Geography (USD MN)
• Nutrition Deficiency Market Sales by Geography (USD MN)
• Cancer Care Market Sales by Geography (USD MN)
• Diabetes Market Sales by Geography (USD MN)
• Chronic Kidney Diseases Market Sales by Geography (USD MN)
• Orphan Diseases Market Sales by Geography (USD MN)
• Dysphagia Market Sales by Geography (USD MN)
• Pain Management Market Sales by Geography (USD MN)
• Malabsorption/GI Disorder/Diarrhea Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospitals (Cardiology, Neurology, Critical Care (ICU), Oncology, Others) Market Sales by Geography (USD MN)
• Home Care Market Sales by Geography (USD MN)
• Global Market Analysis by Sales Channel (USD MN)
• Online Sales Market Sales by Geography (USD MN)
• Institutional Sales Market Sales by Geography (USD MN)
• Retail Sales Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.